HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatima Cardoso Selected Research

Pain (Aches)

1/2018Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fatima Cardoso Research Topics

Disease

92Breast Neoplasms (Breast Cancer)
10/2022 - 07/2002
35Neoplasms (Cancer)
10/2022 - 07/2002
8Neoplasm Metastasis (Metastasis)
04/2022 - 05/2007
4Fatigue
10/2022 - 03/2011
4Disease Progression
04/2021 - 01/2018
2Triple Negative Breast Neoplasms
10/2022 - 01/2020
2Neutropenia
10/2022 - 03/2011
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017 - 02/2016
2Exanthema (Rash)
10/2014 - 08/2005
1Mouth Neoplasms (Oral Cancer)
10/2022
1COVID-19
08/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Bone Diseases (Bone Disease)
01/2019
1Pain (Aches)
01/2018
1Heart Failure
01/2018
1Heart Arrest (Cardiac Arrest)
01/2018
1Sudden Death
01/2018
1Respiratory Insufficiency (Respiratory Failure)
01/2018
1Infections
01/2018
1Frailty
01/2018
1Hypertension (High Blood Pressure)
01/2018
1Male Breast Neoplasms (Male Breast Cancer)
01/2017
1Hypersensitivity (Allergy)
01/2016

Drug/Important Bio-Agent (IBA)

16Trastuzumab (Herceptin)FDA Link
01/2022 - 10/2002
12Estrogen ReceptorsIBA
01/2022 - 12/2004
10Hormones (Hormone)IBA
10/2022 - 12/2009
9Pharmaceutical PreparationsIBA
02/2017 - 06/2004
8TamoxifenFDA LinkGeneric
01/2020 - 12/2004
7Docetaxel (Taxotere)FDA Link
10/2020 - 07/2002
6AnthracyclinesIBA
10/2022 - 02/2006
6ErbB Receptors (EGF Receptor)IBA
10/2022 - 12/2005
6human ERBB2 proteinIBA
01/2021 - 02/2006
6Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 07/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 07/2002
4Letrozole (Femara)FDA LinkGeneric
04/2022 - 01/2008
4Biomarkers (Surrogate Marker)IBA
11/2021 - 04/2011
4Progesterone Receptors (Progesterone Receptor)IBA
02/2021 - 12/2004
4Monoclonal AntibodiesIBA
02/2017 - 12/2005
4ParaffinIBA
12/2008 - 07/2002
3taxaneIBA
10/2022 - 02/2008
3Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 12/2011
3Epirubicin (Ellence)FDA LinkGeneric
10/2022 - 04/2011
3Aromatase InhibitorsIBA
01/2020 - 02/2006
3EverolimusFDA Link
01/2018 - 01/2008
3eribulinFDA Link
01/2016 - 03/2011
3Lapatinib (GW572016)FDA Link
10/2014 - 03/2008
3Biological ProductsIBA
07/2013 - 01/2007
3Sunitinib (Sutent)FDA Link
12/2012 - 08/2009
3Taxoids (Taxanes)IBA
11/2008 - 02/2006
2pembrolizumabIBA
10/2022 - 01/2020
2Carboplatin (JM8)FDA LinkGeneric
10/2022 - 01/2020
2ribociclibIBA
04/2022 - 03/2022
2pertuzumabIBA
01/2022 - 01/2018
2TOR Serine-Threonine KinasesIBA
01/2018 - 08/2005
2Tumor Biomarkers (Tumor Markers)IBA
02/2016 - 04/2008
2Methotrexate (Mexate)FDA LinkGeneric
05/2015 - 07/2002
2Fluorouracil (Carac)FDA LinkGeneric
05/2015 - 07/2002
2Type II DNA Topoisomerases (Topoisomerase II)IBA
04/2011 - 10/2004
2Formaldehyde (Formol)FDA Link
12/2008 - 07/2008
2TubulinIBA
07/2008 - 12/2002
2tau Proteins (tau Protein)IBA
07/2008 - 12/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2008 - 03/2007
2Bortezomib (Velcade)FDA Link
12/2006 - 06/2004
1palbociclibIBA
10/2022
1thiamine triphosphorate (TTP)IBA
04/2022
1RNA (Ribonucleic Acid)IBA
11/2021
1CarbonIBA
04/2021
1margetuximabIBA
04/2021
1EndocineIBA
02/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2021
1Capecitabine (Xeloda)FDA Link
10/2020
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1TESIBA
01/2020
1Excipients (Suspending Agents)IBA
01/2019
1Biosimilar PharmaceuticalsIBA
01/2019
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019
1exemestane (Aromasin)FDA Link
01/2018
1Ado-Trastuzumab EmtansineIBA
01/2018
1Bevacizumab (Avastin)FDA Link
02/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017
1Phenobarbital (Luminal)FDA Link
01/2017
1Messenger RNA (mRNA)IBA
02/2016

Therapy/Procedure

44Therapeutics
10/2022 - 07/2002
20Drug Therapy (Chemotherapy)
10/2022 - 12/2002
12Adjuvant Chemotherapy
10/2020 - 10/2006
4Radiotherapy
02/2021 - 11/2008
3Immunotherapy
01/2019 - 01/2016
2Neoadjuvant Therapy
10/2022 - 01/2020
2Mastectomy (Mammectomy)
01/2022 - 02/2021
1Tattooing
04/2021
1Intravenous Administration
02/2021
1Ambulatory Care (Outpatient Care)
02/2021
1Operative Surgical Procedures
08/2020
1Segmental Mastectomy (Lumpectomy)
01/2020
1Contraindications
01/2020
1Secondary Prevention
01/2019
1Aftercare (After-Treatment)
03/2015
1Terminal Care (Care, Terminal)
03/2015